These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Skin sensitizing effects of sulfur mustard and other alkylating agents in accordance to OECD guidelines. Steinritz D; Lang S; Popp T; Siegert M; Rothmiller S; Kranawetvogl A; Schmidt A; John H; Gudermann T; Thiermann H; Kehe K Toxicol Lett; 2019 Oct; 314():172-180. PubMed ID: 31404593 [TBL] [Abstract][Full Text] [Related]
5. Development of a mouse model for sulfur mustard-induced ocular injury and long-term clinical analysis of injury progression. Ruff AL; Jarecke AJ; Hilber DJ; Rothwell CC; Beach SL; Dillman JF Cutan Ocul Toxicol; 2013 Jun; 32(2):140-9. PubMed ID: 23106216 [TBL] [Abstract][Full Text] [Related]
6. A convenient fluorometric method to study sulfur mustard-induced apoptosis in human epidermal keratinocytes monolayer microplate culture. Ray R; Hauck S; Kramer R; Benton B Drug Chem Toxicol; 2005; 28(1):105-16. PubMed ID: 15720039 [TBL] [Abstract][Full Text] [Related]
7. Postexposure application of Fas receptor small-interfering RNA to suppress sulfur mustard-induced apoptosis in human airway epithelial cells: implication for a therapeutic approach. Keyser BM; Andres DK; Nealley E; Holmes WW; Benton B; Paradiso D; Appell A; Carpin C; Anderson DR; Smith WJ; Ray R J Pharmacol Exp Ther; 2013 Jan; 344(1):308-16. PubMed ID: 23129783 [TBL] [Abstract][Full Text] [Related]
8. Development of a co-culture of keratinocytes and immune cells for in vitro investigation of cutaneous sulfur mustard toxicity. Balszuweit F; Menacher G; Bloemeke B; Schmidt A; Worek F; Thiermann H; Steinritz D Chem Biol Interact; 2014 Nov; 223():117-24. PubMed ID: 25256379 [TBL] [Abstract][Full Text] [Related]
9. TRPA1 and CGRP antagonists counteract vesicant-induced skin injury and inflammation. Achanta S; Chintagari NR; Brackmann M; Balakrishna S; Jordt SE Toxicol Lett; 2018 Sep; 293():140-148. PubMed ID: 29535050 [TBL] [Abstract][Full Text] [Related]
10. B-Raf inhibitor vemurafenib counteracts sulfur mustard-induced epidermal impairment through MAPK/ERK signaling. Xiao Z; Liu F; Cheng J; Wang Y; Zhou W; Zhang Y Drug Chem Toxicol; 2023 Mar; 46(2):226-235. PubMed ID: 34986718 [TBL] [Abstract][Full Text] [Related]
11. Mustard vesicating agent-induced toxicity in the skin tissue and silibinin as a potential countermeasure. Tewari-Singh N; Agarwal R Ann N Y Acad Sci; 2016 Jun; 1374(1):184-92. PubMed ID: 27326543 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of poly(ADP-ribose) polymerase (PARP) influences the mode of sulfur mustard (SM)-induced cell death in HaCaT cells. Kehe K; Raithel K; Kreppel H; Jochum M; Worek F; Thiermann H Arch Toxicol; 2008 Jul; 82(7):461-70. PubMed ID: 18046540 [TBL] [Abstract][Full Text] [Related]
13. Historical perspective on effects and treatment of sulfur mustard injuries. Graham JS; Schoneboom BA Chem Biol Interact; 2013 Dec; 206(3):512-22. PubMed ID: 23816402 [TBL] [Abstract][Full Text] [Related]